Association Between Hemoglobin and Prognosis in Patients Admitted to Hospital for COPD

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2016 Nov 24

PMID 27877035

Citations 23

Authors

Anne Pernille Toft-Petersen

Christian Torp-Pedersen

Ulla Moller Weinreich

Bodil Steen Rasmussen

Affiliations

Soon will be listed here.

Abstract

Low concentrations of hemoglobin have previously been demonstrated in many patients with COPD. There is evidence of anemia as a prognostic factor in acute exacerbations, but the detailed relationship between concentrations of hemoglobin and mortality is not known. A register-based cohort of patients admitted for the first time to Danish hospitals for acute exacerbations of COPD from 2007 through 2012 was established. Age, sex, comorbidities, medication, renal function, and concentrations of hemoglobin were retrieved. Sex-specific survival analyses were fitted for different rounded concentrations of hemoglobin. The cohort encompassed 6,969 patients. Hemoglobin below 130 g/L was present in 39% of males and below 120 g/L in 24% of females. The in-hospital mortality rates for patients with hemoglobin below or above these limits were 11.6% and 5.4%, respectively. After discharge, compared to hemoglobin 130 g/L, the hazard ratio (HR) for males with hemoglobin 120 g/L was 1.45 (95% confidence interval [CI] 1.22-1.73), adjusted HR 1.37 (95% CI 1.15-1.64). Compared to hemoglobin 120 g/L, the HR for females with hemoglobin 110 g/L was 1.4 (95% CI 1.17-1.68), adjusted HR 1.28 (95% CI 1.06-1.53). In conclusion, low concentrations of hemoglobin are frequent in COPD patients with acute exacerbations, and predict long-term mortality.

Citing Articles

Unveiling the Prognostic Power of HRR in ICU-Admitted COPD Patients: A MIMIC-IV Database Study.

Wang Y, Chen D, Zhang C, Yang H Int J Chron Obstruct Pulmon Dis. 2025; 20():11-21.

PMID: 39802039 PMC: 11721526. DOI: 10.2147/COPD.S482344.

Machine learning approach to flare-up detection and clustering in chronic obstructive pulmonary disease (COPD) patients.

Rueda R, Fabello E, Silva T, Genzor S, Mizera J, Stanke L Health Inf Sci Syst. 2024; 12(1):50.

PMID: 39464698 PMC: 11499475. DOI: 10.1007/s13755-024-00308-4.

The Impact of Anemia on Long-Term Mortality in Hospitalized Patients with Exacerbation of Chronic Obstructive Pulmonary Disease.

Garcia-Pachon E, Padilla-Navas I Int J Chron Obstruct Pulmon Dis. 2024; 19:2229-2237.

PMID: 39403170 PMC: 11471888. DOI: 10.2147/COPD.S469627.

Comprehensive time-course gene expression evaluation of high-risk beef cattle to establish immunological characteristics associated with undifferentiated bovine respiratory disease.

Scott M, Valeris-Chacin R, Thompson A, Woolums A, Karisch B Front Immunol. 2024; 15:1412766.

PMID: 39346910 PMC: 11427276. DOI: 10.3389/fimmu.2024.1412766.

Development and validation of a mortality risk prediction model for chronic obstructive pulmonary disease: a cross-sectional study using probabilistic graphical modelling.

Lovelace T, Ryu M, Jia M, Castaldi P, Sciurba F, Hersh C EClinicalMedicine. 2024; 75:102786.

PMID: 39263674 PMC: 11388367. DOI: 10.1016/j.eclinm.2024.102786.

References

Boutou A, Karrar S, Hopkinson N, Polkey M . Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration. 2012; 85(2):126-31. DOI: 10.1159/000338792. View

Roberts C, Lowe D, Bucknall C, Ryland I, Kelly Y, Pearson M . Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2002; 57(2):137-41. PMC: 1746248. DOI: 10.1136/thorax.57.2.137. View

Martinez-Rivera C, Portillo K, Munoz-Ferrer A, Martinez-Ortiz M, Molins E, Serra P . Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD. 2012; 9(3):243-50. DOI: 10.3109/15412555.2011.647131. View

Seyhan E, Ozgul M, Tutar N, Omur I, Uysal A, Altin S . Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD. 2013; 10(4):416-24. DOI: 10.3109/15412555.2012.758697. View

Cote C, Zilberberg M, Mody S, Dordelly L, Celli B . Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007; 29(5):923-9. DOI: 10.1183/09031936.00137106. View

Haja Mydin H, Murphy S, Clague H, Sridharan K, Taylor I . Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013; 8:151-7. PMC: 3610447. DOI: 10.2147/COPD.S39403. View

Rasmussen L, Christensen S, Lenler-Petersen P, Johnsen S . Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation. Clin Epidemiol. 2011; 3:1-5. PMC: 3035601. DOI: 10.2147/CLEP.S12885. View

Kent B, Mitchell P, McNicholas W . Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011; 6:199-208. PMC: 3107696. DOI: 10.2147/COPD.S10611. View

Han M, Agusti A, Calverley P, Celli B, Criner G, Curtis J . Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010; 182(5):598-604. PMC: 6850732. DOI: 10.1164/rccm.200912-1843CC. View

10.

Nilsson-Ehle H, Jagenburg R, Landahl S, Svanborg A . Blood haemoglobin declines in the elderly: implications for reference intervals from age 70 to 88. Eur J Haematol. 2000; 65(5):297-305. DOI: 10.1034/j.1600-0609.2000.065005297.x. View

11.

Coleta K, Silveira L, Lima D, Rampinelli E, Godoy I, Godoy I . Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy. Respir Med. 2008; 102(4):512-8. DOI: 10.1016/j.rmed.2007.12.003. View

12.

Lima D, Coleta K, Tanni S, Silveira L, Godoy I, Godoy I . Potentially modifiable predictors of mortality in patients treated with long-term oxygen therapy. Respir Med. 2010; 105(3):470-6. DOI: 10.1016/j.rmed.2010.08.012. View

13.

Similowski T, Agusti A, MacNee W, Schonhofer B . The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006; 27(2):390-6. DOI: 10.1183/09031936.06.00143704. View

14.

Connors Jr A, Dawson N, Thomas C, Harrell Jr F, Desbiens N, Fulkerson W . Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996; 154(4 Pt 1):959-67. DOI: 10.1164/ajrccm.154.4.8887592. View

15.

Berry C, Wise R . Mortality in COPD: causes, risk factors, and prevention. COPD. 2010; 7(5):375-82. PMC: 7273182. DOI: 10.3109/15412555.2010.510160. View

16.

Rohrig G . Anemia in the frail, elderly patient. Clin Interv Aging. 2016; 11:319-26. PMC: 4803240. DOI: 10.2147/CIA.S90727. View

17.

Divo M, Cote C, de Torres J, Casanova C, Marin J, Pinto-Plata V . Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(2):155-61. DOI: 10.1164/rccm.201201-0034OC. View

18.

Kumler T, Gislason G, Kirk V, Bay M, Nielsen O, Kober L . Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008; 10(7):658-60. DOI: 10.1016/j.ejheart.2008.05.006. View

19.

Dal Negro R, Bonadiman L, Turco P . Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med. 2015; 10(1):24. PMC: 4525744. DOI: 10.1186/s40248-015-0023-2. View

20.

Kollert F, Tippelt A, Muller C, Jorres R, Porzelius C, Pfeifer M . Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care. 2012; 58(7):1204-12. DOI: 10.4187/respcare.01961. View